bioAffinity Technologies (BIAF) Times Interest Earned (2021 - 2026)
bioAffinity Technologies (BIAF) reported Times Interest Earned of -$404.67 for Q1 2026, down 138.52% year-over-year from $1050.4 in Q1 2025, and down 5977.61% quarter-over-quarter from -$6.66 in Q4 2025.
bioAffinity Technologies (BIAF) Times Interest Earned (2021 - 2026) Analysis & Trends
bioAffinity Technologies (BIAF) has 6 years of Times Interest Earned data on file, last reported at -$404.67 in Q1 2026.
- Times Interest Earned for Q1 2026 came in at -$404.67, down 138.52% year-over-year; the trailing twelve-month figure through Mar 2026 was -$11.96 (up 93.49% YoY), and the FY2025 annual result was -$21.04, up 97.6% from the prior year.
- Times Interest Earned fell to -$404.67 in Q1 2026 per BIAF's latest filing, from -$6.66 in the prior quarter.
- Over five years, Times Interest Earned peaked at -$1.09 in Q3 2022 and troughed at -$368319.1 in Q4 2024.
- A 5-year average of -$23275.8 and a median of -$148.6 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 220365.82% in 2024, then jumped 100.0% in 2025.
- A 5-year view of Times Interest Earned shows it stood at -$18.19 in 2022, then slumped by 818.69% to -$167.06 in 2023, then plunged by 220365.82% to -$368319.1 in 2024, then jumped by 100.0% to -$6.66 in 2025, then plunged by 5977.61% to -$404.67 in 2026.
- Business Quant data shows BIAF's Times Interest Earned at -$404.67 in Q1 2026, -$6.66 in Q4 2025, and -$597.25 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,149.49 Bn | 29,149.03 Bn | 1.11 Bn | -0.98 |
| 2 | Thermo Fisher Scientific | 174.37 Bn | 171.12 Bn | 7.74 Bn | 5.26 |
| 3 | Danaher | 127.33 Bn | 121.64 Bn | 3.59 Bn | 21.33 |
| 4 | Idexx Laboratories | 44.68 Bn | 44.48 Bn | 722.74 Mn | 46.84 |
| 5 | Agilent Technologies | 36.54 Bn | 34.74 Bn | 990.00 Mn | 15.96 |
| 6 | Iqvia Holdings | 30.51 Bn | 28.53 Bn | 1.36 Bn | 2.68 |
| 7 | Natera | 30.00 Bn | 28.90 Bn | 696.04 Mn | -104.84 |
| 8 | Illumina | 24.61 Bn | 23.45 Bn | 721.00 Mn | 8.71 |
| 9 | Mettler Toledo International | 22.91 Bn | 22.85 Bn | 555.82 Mn | 14.05 |
| 10 | bioAffinity Technologies | 1.98 Mn | -1.12 Mn | - | -404.67 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -404.67 |
| Dec 31, 2025 | -6.66 |
| Sep 30, 2025 | -597.25 |
| Jun 30, 2025 | -5.21 |
| Mar 31, 2025 | -169.66 |
| Dec 31, 2024 | -368,319.13 |
| Sep 30, 2024 | -134.30 |
| Jun 30, 2024 | -93.84 |
| Mar 31, 2024 | -82.60 |
| Dec 31, 2023 | -167.06 |
| Sep 30, 2023 | -162.90 |
| Jun 30, 2023 | -1,307.61 |
| Mar 31, 2023 | -941.37 |
| Dec 31, 2022 | -18.19 |
| Sep 30, 2022 | -1.09 |
| Jun 30, 2022 | -1.71 |
| Dec 31, 2021 | -1.03 |
| Sep 30, 2021 | -3.89 |